The Halt 2000GI Electrosurgical System for soft tissue ablation using radiofrequency energy has been cleared by the US Food and Drug Administration (FDA).

Halt says its system provides an easier way to perform surgery.

The system inserts a slender probe into a target tumour using ultrasound guidance. The heat generated during this process destroys the tumour, allowing it to be absorbed by the body.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData